Penbraya approval sparks shift to pentavalent meningococcal vaccines in US: GlobalData
GSK is also in the process of developing a pentavalent vaccine, and positive Phase III data were announced earlier this year.…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Lupin, Zydus sign licensing pact to co-market Saroglitazar Mg for chronic liver diseases in India
In 2020, Saroglitazar Mg received approval for the treatment of NASH and NAFLD
Novel therapies to drive Crohn’s disease market growth across 8MM to $15 bn by 2032: GlobalData
An anticipated 11 assets in the late-stage pipeline will enter the CD market during the forecast period
ImmunoACT to lead journey of indigenous CAR-T cell therapy in India but market access a hurdle:…
As per ImmunoACT CEO, NexCAR19 will be available at a price of Rs 30-40 lakh ($36,000- $48,000), which is 1/10th of the cost of…
Zydus acquires LiqMeds Group
Zydus will pay an upfront consideration of GBP 68 million and yearly earn-outs until 2026 depending on achievement of certain…
Aragen setting up a $ 30mn bio-manufacturing site in Bengaluru
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
FDA rejection to delay Lebrikizumab chances to enter atopic dermatitis market: GlobalData
GlobalData currently expects Lilly to resubmit lebrikizumab’s BLA in Q4 2023
Pharma, healthcare sector attract investment despite volume dip in Q3 2023: Report
The quarter saw 26 deals totalling $2.7 billion, with a 32 per cent decline in deal volumes compared to Q3 2022
Top 20 global biopharma cos report marginal growth in market cap during Q3 2023: GlobalData
Out of the top 20 companies, nine saw their market capitalisation surge by more than 10 per cent, with significant gains achieved…
Sun Pharma, Zydus sign licensing pact to co-market Desidustat for CKD treatment in India
The drug will be marketed by Sun Pharma under the brand name RYTSTAT. Zydus continues to market the drug under the brand name…
Venus Remedies gets market authorisation for Bleomycin 15,000 IU in the UK
Venus Remedies holds a total of 15 MA for Bleomycin products across the globe
DCGI approves KEYTRUDA to treat triple negative breast cancer, renal cell carcinoma
KEYTRUDA is now approved for 14 indications across eight tumour types in India
Dr Reddy’s launches D2C e-commerce website ‘Celevida Wellness’ for diabetes
Launch enables the company to reach more consumers, strengthens play in nutraceuticals which started in 2019 through its flagship…
WHO trivalent recommendations will reshape global flu vaccine market: GlobalData
WHO recently advised a reversion to trivalent (three-strain) influenza vaccines for the 2024 southern hemisphere influenza…
Zydus begins Phase II trial of ZYIL1, NLRP3 inhibitor in patients with ALS
USFDA has granted Zydus an ‘Orphan Drug Designation’ for ZYIL1 to treat patients with Cryopyrin Associated Periodic Syndrome…
Venus Remedies gets REO Certification from CII for second consecutive year
The REO certification is a recognition awarded by the CII for responsible and sustainable export practices
Axplora appoints Dr Stephan Haitz as President of Novasep CDMO Business Unit
He will take over from Jean Bléhaut, who leaves the company after a career spanning more than 25 years
Aragen commissions new formulations manufacturing facility in Hyderabad
Aragen has commissioned its new formulations manufacturing facility in Hyderabad, India. This facility, set up at an investment of…
Biotech startup Mestastop raises $ 500k for cancer drug discovery and repurposing technology
The funds will be used to generate proof of concept data with small molecules around the identified first-in-class targets and…
Glenmark Pharma launches triple-drug FDC of Teneligliptin + Dapagliflozin + Metformin in India
Zita DM helps improve glycemic control in adult patients with high HbA1c and/or other co-morbidities, those patients whose…